Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Jun 25;13(6):e15911.
doi: 10.7759/cureus.15911. eCollection 2021 Jun.

Synchronous Small Bowel Gangrene With Pyelonephritis Secondary to Mucormycosis: A Disastrous Complication of COVID-19 Pandemic

Affiliations
Case Reports

Synchronous Small Bowel Gangrene With Pyelonephritis Secondary to Mucormycosis: A Disastrous Complication of COVID-19 Pandemic

Vaibhav K Varshney et al. Cureus. .

Abstract

Mucormycosis is a rare infection caused by fungi of the order Mucorales. The infection frequently involves the rhino-cerebral or respiratory system and involvement of the gastrointestinal (GI) tract and kidney are rare. It usually infects immunocompromised individuals due to various causes and an upsurge is hypothesized to be linked with irrational use of steroids during coronavirus disease 2019 (COVID-19) pandemic. We encountered a rare case of systemic mucormycosis that involved both renal as well as mesenteric vessels and led to ischemia of both vital organs. The patient developed massive bowel gangrene involving the duodenum, proximal jejunum, and left kidney due to angioinvasive mucormycosis. The diagnosis of GI mucormycosis may further increase during the current pandemic. The physicians, as well as surgeons, should be aware of this unwanted complication and keep a high index of suspicion for this rare disease.

Keywords: angioinvasive; bowel gangrene; covid-19; gastrointestinal mucormycosis; vascular necrosis.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Intra-operative images.
a) Resected specimen of bulky left kidney with areas of necrosis; b) Gangrenous bowel along with thickened mesentery
Figure 2
Figure 2. Histopathology images.
a) Necrosis and shedding of epithelial cells of renal tubules in the presence of multiple foldable, broad aseptate fungal hyphae of mucor species; b) Mesenteric vein thrombosis and fungal hyphae in the vessel wall (arrow pointed); c) Periodic acid stain positive fungal hyphae (arrow pointed); d) Grocott’s methanamine silver positive fungal hyphae (arrow pointed).

References

    1. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports. Jeong W, Keighley C, Wolfe R, et al. Clin Microbiol Infect. 2019;25:26–34. - PubMed
    1. Gastrointestinal mucormycosis: an evolving disease. Spellberg B. https://pubmed.ncbi.nlm.nih.gov/22485085/ Gastroenterol Hepatol (NY) 2012;8:140–142. - PMC - PubMed
    1. Gastrointestinal mucormycosis in immunocompromised hosts. Dioverti MV, Cawcutt KA, Abidi M, et al. Mycoses. 2015;58:714–718. - PubMed
    1. Epidemiology and diagnosis of mucormycosis: an update. Skiada A, Pavleas I, Drogari-Apiranthitou M. J Fungi (Basel) 2020;2:265. - PMC - PubMed
    1. Recent advances in the understanding and management of mucormycosis. Pilmis B, Alanio A, Lortholary O, et al. F1000Res. 2018;7:0–1429. - PMC - PubMed

Publication types

LinkOut - more resources